Stockscreener 앱 받기
18.00
6.10%
1.035
전일 마감가:
$16.97
열려 있는:
$16.91
하루 거래량:
366.63K
Relative Volume:
0.94
시가총액:
$326.50M
수익:
$1.93M
순이익/손실:
$-7.96M
주가수익비율:
-0.0051
EPS:
-3530.8178
순현금흐름:
$-36.78M
1주 성능:
-2.94%
1개월 성능:
+11.90%
6개월 성능:
+313.91%
1년 성능:
+80.05%
1일 변동 폭
$16.63
$18.80
1주일 범위
$15.53
$19.25
52주 변동 폭
$3.39
$19.41
아발로 테라퓨틱스 Stock (AVTX) Company Profile
명칭
Avalo Therapeutics Inc
전화
410-522-8707
주소
1500 LIBERTY RIDGE DRIVE, WAYNE
AVTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
18.00 | 307.73M | 1.93M | -7.96M | -36.78M | -3,530.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
아발로 테라퓨틱스 Stock (AVTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-17 | 재확인 | H.C. Wainwright | Buy |
| 2025-09-05 | 개시 | TD Cowen | Buy |
| 2025-08-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-06-02 | 재개 | H.C. Wainwright | Buy |
| 2025-03-25 | 개시 | Jefferies | Buy |
| 2025-03-25 | 개시 | Stifel | Buy |
| 2025-02-28 | 개시 | Piper Sandler | Overweight |
| 2025-02-21 | 개시 | Wedbush | Outperform |
| 2024-12-19 | 개시 | BTIG Research | Buy |
| 2024-10-24 | 개시 | H.C. Wainwright | Neutral |
| 2024-04-16 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-09-24 | 개시 | RBC Capital Mkts | Outperform |
모두보기
아발로 테라퓨틱스 주식(AVTX)의 최신 뉴스
Why analysts maintain buy rating on Avalo Therapeutics Inc. (C6K0) stockWeekly Risk Report & Reliable Intraday Trade Alerts - Newser
Why Avalo Therapeutics Inc. (C6K0) stock could be next leaderGlobal Markets & Expert Curated Trade Setup Alerts - Newser
Why Avalo Therapeutics Inc. (C6K0) stock stays resilient2025 Support & Resistance & Risk Managed Investment Strategies - Newser
How buybacks impact Avalo Therapeutics Inc. stock value2025 Winners & Losers & Low Risk Investment Opportunities - Newser
What hedge fund activity signals for Avalo Therapeutics Inc. stockDip Buying & Low Drawdown Trading Techniques - Newser
Financial Comparison: InMed Pharmaceuticals (NASDAQ:INM) & Avalo Therapeutics (NASDAQ:AVTX) - Defense World
Is Avalo Therapeutics Inc. (C6K0) stock a top dividend aristocrat candidateNew Guidance & Safe Entry Momentum Tips - Newser
Published on: 2025-12-03 02:49:42 - Newser
Is Avalo Therapeutics Inc. (C6K0) stock overpriced at current multiplesWeekly Market Summary & Low Drawdown Investment Ideas - Newser
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives $31.67 Average PT from Analysts - Defense World
Taking the lead: Avalo Therapeutics Inc (AVTX) - Setenews
How Avalo Therapeutics Inc. stock benefits from strong dollarTrade Exit Summary & AI Based Buy and Sell Signals - Newser
Avalo Therapeutics, Inc. Updates Investor Presentation - TradingView
Is Avalo Therapeutics Inc. (C6K0) stock resilient in recession scenariosWeekly Risk Summary & Smart Allocation Stock Reports - Newser
What is the fair value of Avalo Therapeutics Inc. stock nowInflation Watch & Risk Controlled Stock Pick Alerts - Newser
How Avalo Therapeutics Inc. (C6K0) stock performs in easing cyclesGap Up & Community Consensus Trade Alerts - Newser
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Avalo Therapeutics Reports Q3 2025 Financial Results - MSN
HC Wainwright Has Bearish Estimate for AVTX FY2025 Earnings - Defense World
How Avalo Therapeutics Inc. (C6K0) stock stacks up against competitorsJuly 2025 Spike Watch & Risk Controlled Daily Trade Plans - newser.com
What valuation ratios show for Avalo Therapeutics Inc. (C6K0) stockRate Hike & Fast Momentum Stock Entry Tips - newser.com
How Avalo Therapeutics Inc. (C6K0) stock valuation compares with sectorMarket Activity Recap & Weekly Momentum Picks - newser.com
Is Avalo Therapeutics Inc. stock supported by strong cash flowsMarket Performance Recap & Smart Swing Trading Alerts - newser.com
Has Avalo Therapeutics Inc. formed a bullish divergenceJuly 2025 Sentiment & Accurate Technical Buy Alerts - newser.com
D pipelineJuly 2025 Market Mood & Technical Pattern Recognition Alerts - newser.com
Avalo Therapeutics, Inc. (AVTX) -3.17% in Pre-market: Stock Slides Amid Recent Developments - Stocks Telegraph
Can Avalo Therapeutics Inc. (C6K0) stock test all time highsChart Signals & Comprehensive Market Scan Reports - newser.com
아발로 테라퓨틱스 (AVTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.10%
1.10%
자본화:
|
볼륨(24시간):